Authors field exact matches “Wakabayashi Rie”; 18 programs are found. (“Poster with Flash” presentations are double-counted.)
The search results are sorted by the start time.
Time | Paper ID | Title / Authors | Keywords | Topic code | Ack. number |
---|---|---|---|---|---|
Day 1 | VL119 | Fabrication of peptidic self-assembled fibers that can be post-modified with proteins and their vaccine application | Self-assembled peptide enzymatic post-modification vaccine | SY-68 | 344 |
Day 1 | Chair: | ||||
VL119 | Fabrication of peptidic self-assembled fibers that can be post-modified with proteins and their vaccine application | Self-assembled peptide enzymatic post-modification vaccine | SY-68 | 344 | |
VL120 | Development of B cell lymphoma 3D culture model | B cell lymphoma 3D culture | SY-68 | 873 | |
VL121 | Double-cooperative effects between antimicrobial peptides towards the development of antimicrobial agents | antimicrobial peptide cooperative effect lipid bilayer | SY-68 | 239 | |
Day 2 | PB204 | Creation of Non-invasive Vaccine patches and Evaluation of Their Functionality | transdermal vaccine patch | SY-67 | 273 |
Day 2 | PB205 | Application of Solid-in-Oil Technology to Transdermal Malaria Vaccine | Transdermal vaccine delivery Transdermal protein delivery Malaria | SY-67 | 279 |
Day 2 | PB207 | Development of transdermal formulation for dementia treatment using next-generation transdermal absorption technology | transdermal delivery donepezil hydrochloride dementia | SY-67 | 486 |
Day 2 | PB208 | Development of Highly Efficient Transdermal Drug Delivery System for Biopharmaceutical Applications | Transdermal vaccine delivery Glyceryl monooleate Transdermal protein delivery | SY-67 | 487 |
Day 2 | PB211 | Controlled Drug Release from Cubic Liquid Crystals for Transdermal Drug Delivery Systems | Liquid crystal transcutaneous drug delivery controlled release | SY-67 | 660 |
Day 2 | PB227 | Study on the selective localization of artificial lipid-modified proteins to lipid membrane domains | Enzymatic lipidation Lipid-protein conjugate Lipid domain | SY-67 | 497 |
Day 2 | PB228 | Extending a functionality of protein assembly by enzyme-mediated post modification | Microbial transglutaminase Protein assembly Post modification | SY-67 | 578 |
Day 2 | PB229 | Development of a polymeric carrier protein presenting a cancer peptide antigen | Peptide antigen Polymerization Cancer | SY-67 | 674 |
Day 2 | PB205 | Application of Solid-in-Oil Technology to Transdermal Malaria Vaccine | Transdermal vaccine delivery Transdermal protein delivery Malaria | SY-67 | 279 |
Day 2 | PB207 | Development of transdermal formulation for dementia treatment using next-generation transdermal absorption technology | transdermal delivery donepezil hydrochloride dementia | SY-67 | 486 |
Day 2 | PB211 | Controlled Drug Release from Cubic Liquid Crystals for Transdermal Drug Delivery Systems | Liquid crystal transcutaneous drug delivery controlled release | SY-67 | 660 |
Day 2 | PB227 | Study on the selective localization of artificial lipid-modified proteins to lipid membrane domains | Enzymatic lipidation Lipid-protein conjugate Lipid domain | SY-67 | 497 |
Day 2 | PB229 | Development of a polymeric carrier protein presenting a cancer peptide antigen | Peptide antigen Polymerization Cancer | SY-67 | 674 |
Day 2 | PB204 | Creation of Non-invasive Vaccine patches and Evaluation of Their Functionality | transdermal vaccine patch | SY-67 | 273 |
Day 2 | PB208 | Development of Highly Efficient Transdermal Drug Delivery System for Biopharmaceutical Applications | Transdermal vaccine delivery Glyceryl monooleate Transdermal protein delivery | SY-67 | 487 |
Day 2 | PB228 | Extending a functionality of protein assembly by enzyme-mediated post modification | Microbial transglutaminase Protein assembly Post modification | SY-67 | 578 |
DispCtl: |
---|
Technical program
Technical sessions (Wide)
(For narrow screen)
Session programs
Search in technical program
SCEJ 52nd Autumn Meeting (Okayama, 2021)